tradingkey.logo
tradingkey.logo
Search

Ironwood Pharmaceuticals Inc

IRWD
Add to Watchlist
4.390USD
+0.160+3.78%
Close 07-31 16:00ETQuotes delayed by 15 min
722.65MMarket Cap
6.98P/E TTM

IRWD Financials

See Ironwood Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Ironwood Pharmaceuticals Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/0.36
Revenue / Forecast
--/114.84M
Period
FY2025 Earnings
Revenue(YoY)
296.15M
-15.72%
EPS(YoY)
0.15
2564.74%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
207.41%0.25
-233.59%-0.02
982.26%0.25
2797.23%0.15
-780.07%-0.23
302.44%0.01
-76.77%0.02
99.92%-0.01
-108.92%-0.03
-102.19%-0.01
--0.10
---6.84
--0.30
--0.32
----
----
----
----
----
----
Revenue
158.87%106.51M
-47.31%47.71M
33.26%122.06M
-9.70%85.24M
-45.05%41.14M
-22.98%90.55M
-19.47%91.59M
-12.09%94.40M
-28.05%74.88M
9.66%117.55M
4.70%113.74M
10.44%107.38M
6.70%104.06M
-8.48%107.20M
4.71%108.64M
-6.54%97.23M
9.77%97.53M
0.39%117.13M
0.27%103.75M
16.32%104.03M
Net Profit
209.06%40.77M
-200.89%-2.28M
999.29%40.08M
2844.07%23.60M
-798.27%-37.39M
307.54%2.26M
-76.20%3.65M
99.92%-860.00K
-109.10%-4.16M
-102.22%-1.09M
-69.55%15.32M
-2964.58%-1.06B
17.82%45.71M
18.11%48.87M
-9.90%50.32M
-90.52%37.08M
-2.82%38.80M
-4.24%41.37M
62.23%55.84M
1452.54%391.30M
Net Margin
142.13%38.28%
-291.47%-4.77%
724.89%32.84%
3138.84%27.69%
-1534.78%-90.87%
267.85%2.49%
-67.54%3.98%
99.91%-0.91%
-112.65%-5.56%
-103.26%-1.48%
--12.26%
---1014.58%
--43.93%
--45.59%
----
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
Debt to assets ratio
-24.61%134.58%
-11.48%147.31%
-4.00%147.58%
8.09%170.39%
16.36%178.53%
12.34%166.42%
11.52%153.73%
19.30%157.64%
341.86%153.43%
311.45%148.14%
--137.86%
--132.13%
--34.72%
--36.01%
----
----
----
----
----
----
Revenue
158.87%106.51M
-47.31%47.71M
33.26%122.06M
-9.70%85.24M
-45.05%41.14M
-22.98%90.55M
-19.47%91.59M
-12.09%94.40M
-28.05%74.88M
9.66%117.55M
4.70%113.74M
10.44%107.38M
6.70%104.06M
-8.48%107.20M
4.71%108.64M
-6.54%97.23M
9.77%97.53M
0.39%117.13M
0.27%103.75M
16.32%104.03M
Operating profit
781.19%72.53M
-79.24%6.55M
202.84%77.68M
66.66%45.07M
-192.94%-10.65M
-26.95%31.56M
-42.62%25.65M
33.08%27.04M
-80.94%11.46M
-36.79%43.21M
-34.71%44.71M
-63.49%20.32M
3.89%60.10M
20.80%68.36M
5.18%68.47M
-14.13%55.66M
26.86%57.85M
-11.23%56.59M
38.96%65.10M
98.14%64.82M
Net Profit
209.06%40.77M
-200.89%-2.28M
999.29%40.08M
2844.07%23.60M
-798.27%-37.39M
307.54%2.26M
-76.20%3.65M
99.92%-860.00K
-109.10%-4.16M
-102.22%-1.09M
-69.55%15.32M
-2964.58%-1.06B
17.82%45.71M
18.11%48.87M
-9.90%50.32M
-90.52%37.08M
-2.82%38.80M
-4.24%41.37M
62.23%55.84M
1452.54%391.30M
Current assets
106.93%332.29M
50.34%274.18M
53.32%273.84M
7.62%191.75M
-22.86%160.58M
-21.83%182.37M
-29.58%178.60M
-43.90%178.18M
-75.97%208.17M
-70.12%233.29M
-63.72%253.61M
-48.59%317.60M
22.01%866.37M
4.75%780.63M
0.52%698.99M
-0.39%617.83M
31.93%710.10M
50.30%745.23M
60.48%695.37M
65.73%620.27M
Total current liabilities
391.31%236.31M
523.53%242.22M
391.07%242.50M
410.93%232.53M
-80.95%48.10M
-85.93%38.85M
-82.40%49.38M
-85.10%45.51M
958.77%252.44M
981.69%276.10M
934.70%280.58M
1210.80%305.39M
-83.82%23.84M
-84.21%25.52M
-81.39%27.12M
-82.66%23.30M
524.51%147.40M
402.59%161.70M
342.83%145.69M
403.35%134.37M
Total assets
32.81%434.57M
13.11%396.90M
1.68%396.06M
-13.31%342.95M
-25.43%327.21M
-25.51%350.91M
-25.67%389.52M
-34.42%395.62M
-62.02%438.82M
-57.20%471.07M
-49.63%524.06M
-38.18%603.22M
6.64%1.16B
-2.34%1.10B
-3.62%1.04B
-3.13%975.69M
80.76%1.08B
101.51%1.13B
119.24%1.08B
127.09%1.01B
Total liabilities
-1.45%651.71M
1.00%658.74M
-5.80%660.22M
-9.23%651.11M
-14.05%661.27M
-20.20%652.24M
-17.52%700.85M
-24.49%717.35M
71.56%769.34M
82.39%817.37M
89.13%849.74M
114.54%950.00M
-20.72%448.43M
-13.99%448.14M
-10.04%449.28M
-10.63%442.81M
15.63%565.60M
4.92%521.02M
2.67%499.43M
3.14%495.46M
Total equity
35.00%-217.14M
13.11%-261.83M
15.15%-264.16M
4.22%-308.16M
-1.07%-334.05M
12.98%-301.33M
4.40%-311.33M
7.22%-321.73M
-146.76%-330.52M
-153.08%-346.30M
-155.10%-325.68M
-165.08%-346.78M
36.52%706.85M
7.67%652.38M
1.92%591.06M
4.13%532.88M
369.89%517.78M
867.29%605.91M
9722.85%579.94M
1488.68%511.76M
Net operating income
-74.34%5.12M
390.17%74.58M
381.37%47.58M
-145.03%-15.07M
-55.64%19.95M
-57.54%15.21M
-69.55%9.88M
-4.28%33.47M
-43.89%44.98M
-54.74%35.83M
-53.02%32.46M
-43.02%34.96M
25.02%80.17M
22.63%79.18M
-7.96%69.09M
26.35%61.37M
-12.99%64.12M
25.34%64.57M
39.96%75.06M
141.78%48.57M
Net investment
----
--1.00K
87.50%-2.00K
96.55%-2.00K
54.41%-31.00K
100.00%0.00
99.93%-16.00K
99.99%-58.00K
-423.08%-68.00K
-15611.11%-4.19M
-34180.30%-22.63M
-1135686.36%-999.49M
-44.44%-13.00K
121.09%27.00K
51.82%-66.00K
---88.00K
---9.00K
-357.14%-128.00K
---137.00K
----
Net financing
----
100.82%122.00K
100.00%0.00
100.18%88.00K
100.04%6.00K
70.75%-14.89M
63.79%-27.16M
-112.37%-49.37M
-490.73%-15.55M
-1914.11%-50.90M
-9508.78%-74.99M
365.55%399.07M
104.38%3.98M
115.10%2.81M
-87.07%797.00K
-2754.24%-150.28M
-4210.04%-90.87M
-627.44%-18.59M
820.00%6.16M
136.21%5.66M

FAQs

What is the total revenue of Ironwood Pharmaceuticals Inc?

According to Ironwood Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 296.15M, with a year-on-year change of 351.41M.

What are the current assets of Ironwood Pharmaceuticals Inc?

According to Ironwood Pharmaceuticals Inc's FY2025 earnings report, its current assets were 274.18M, with a year-on-year change of 50.34.

What are the total assets of Ironwood Pharmaceuticals Inc?

According to Ironwood Pharmaceuticals Inc's FY2025 earnings report, its total assets of Ironwood Pharmaceuticals Inc were 396.90M, with a year-on-year change of 13.11.

What are the total liabilities of Ironwood Pharmaceuticals Inc?

According to Ironwood Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Ironwood Pharmaceuticals Inc were 658.74M, with a year-on-year change of 1.00.

What is the total equity of Ironwood Pharmaceuticals Inc?

According to Ironwood Pharmaceuticals Inc's FY2025 earnings report, its total equity of Ironwood Pharmaceuticals Inc was -261.83M, with a year-on-year change of 13.11.

What is the net operating income of Ironwood Pharmaceuticals Inc?

According to Ironwood Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Ironwood Pharmaceuticals Inc was 118.76M, with a year-on-year change of 24.07.

What is the net investment of Ironwood Pharmaceuticals Inc?

According to Ironwood Pharmaceuticals Inc's FY2025 earnings report, its net investment of Ironwood Pharmaceuticals Inc was -34.00K, with a year-on-year change of 76.06.

What is the net financing of Ironwood Pharmaceuticals Inc?

According to Ironwood Pharmaceuticals Inc's FY2025 earnings report, its net financing of Ironwood Pharmaceuticals Inc was 216.00K, with a year-on-year change of 100.20.

What is the Earnings Per Share (EPS) of Ironwood Pharmaceuticals Inc?

According to Ironwood Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 0.15, with a year-on-year change of 2564.74.

What is the net income of Ironwood Pharmaceuticals Inc?

According to Ironwood Pharmaceuticals Inc's FY2025 earnings report, its net income was 24.02M, with a year-on-year change of 2629.20.

What is the net margin of Ironwood Pharmaceuticals Inc?

According to Ironwood Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was 8.11, with a year-on-year change of 3138.57.

What is the debt-to-asset ratio of Ironwood Pharmaceuticals Inc?

According to Ironwood Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 147.31, with a year-on-year change of -11.48.

What is the Return on Assets (ROA) of Ironwood Pharmaceuticals Inc?

According to Ironwood Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was 6.42, with a year-on-year change of 2899.90.

What is the operating profit of Ironwood Pharmaceuticals Inc?

According to Ironwood Pharmaceuticals Inc's FY2025 earnings report, its operating profit was 118.76M, with a year-on-year change of 24.07.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.